Halloran PF - Search Results

1

A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.

Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. Doberer K, et al. Among authors: halloran pf. J Am Soc Nephrol. 2021 Mar;32(3):708-722. doi: 10.1681/ASN.2020071106. Epub 2020 Dec 18. J Am Soc Nephrol. 2021. PMID: 33443079 Free PMC article. Clinical Trial.

2

The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.

Halloran PF, Schlaut J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1992 Mar;53(3):550-5. Transplantation. 1992. PMID: 1549846

3

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection.

Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. Halloran PF, et al. Transplantation. 1990 Jan;49(1):85-91. doi: 10.1097/00007890-199001000-00019. Transplantation. 1990. PMID: 2301035

4

Ly-6 in kidney is widely expressed on tubular epithelium and vascular endothelium and is up-regulated by interferon gamma.

Blake PG, Madrenas J, Halloran PF. Blake PG, et al. Among authors: halloran pf. J Am Soc Nephrol. 1993 Nov;4(5):1140-50. doi: 10.1681/ASN.V451140. J Am Soc Nephrol. 1993. PMID: 8305641

5

Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury.

Goes N, Urmson J, Vincent D, Ramassar V, Halloran PF. Goes N, et al. Among authors: halloran pf. J Am Soc Nephrol. 1996 May;7(5):710-20. doi: 10.1681/ASN.V75710. J Am Soc Nephrol. 1996. PMID: 8738806

6

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Halloran P, et al. Transplantation. 1997 Jan 15;63(1):39-47. doi: 10.1097/00007890-199701150-00008. Transplantation. 1997. PMID: 9000658 Clinical Trial.

7

Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

Halloran PF, Melk A, Barth C. Halloran PF, et al. J Am Soc Nephrol. 1999 Jan;10(1):167-81. doi: 10.1681/ASN.V101167. J Am Soc Nephrol. 1999. PMID: 9890324 Review. No abstract available.

8

Telomere shortening in kidneys with age.

Melk A, Ramassar V, Helms LMH, Moore R, Rayner D, Solez K, Halloran PF. Melk A, et al. Among authors: halloran pf. J Am Soc Nephrol. 2000 Mar;11(3):444-453. doi: 10.1681/ASN.V113444. J Am Soc Nephrol. 2000. PMID: 10703668

9

Time dependency of factors affecting renal allograft survival.

Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Prommool S, et al. Among authors: halloran pf. J Am Soc Nephrol. 2000 Mar;11(3):565-573. doi: 10.1681/ASN.V113565. J Am Soc Nephrol. 2000. PMID: 10703681

10

Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection.

Afrouzian M, Ramassar V, Urmson J, Zhu LF, Halloran PF. Afrouzian M, et al. Among authors: halloran pf. J Am Soc Nephrol. 2002 May;13(5):1199-209. doi: 10.1097/01.asn.0000013302.11876.a5. J Am Soc Nephrol. 2002. PMID: 11961007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters